Comparison between Bafna Pharmaceuticals IPO and Sejal Architectural Glass IPO.
Bafna Pharmaceuticals IPO is a Mainboard Bookbuilding IPO proposed to list at BSE while Sejal Architectural Glass IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Bafna Pharmaceuticals IPO is up to ₹25.60 Cr whereas the issue size of the Sejal Architectural Glass IPO is up to ₹105.73 Cr. The final issue price of Bafna Pharmaceuticals IPO is ₹40.00 per share and of Sejal Architectural Glass IPO is ₹115.00 per share.
| Bafna Pharmaceuticals IPO | Sejal Architectural Glass IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹105.00 per share | |
| Issue Price (Upper) | ₹115.00 per share | |
| Issue Price (Final) | ₹40.00 per share | ₹115.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 60 shares | |
| Fresh Issue Size | 64,00,206 shares | 91,94,155 shares |
| Fresh Issue Size (Amount) | up to ₹25.60 Cr | up to ₹105.73 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 64,00,206 shares | 91,94,155 shares |
| Issue Size Total (Amount) | up to ₹25.60 Cr | up to ₹105.73 Cr |
Bafna Pharmaceuticals IPO opens on May 27, 2008, while Sejal Architectural Glass IPO opens on Jun 09, 2008. The closing date of Bafna Pharmaceuticals IPO and Sejal Architectural Glass IPO is May 30, 2008, and Jun 12, 2008, respectively.
| Bafna Pharmaceuticals IPO | Sejal Architectural Glass IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | May 27, 2008 | Jun 09, 2008 |
| Issue Close | May 30, 2008 | Jun 12, 2008 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Jun 27, 2008 | Jul 01, 2008 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Bafna Pharmaceuticals IPO P/E ratio is , as compared to Sejal Architectural Glass IPO P/E ratio of .
| Bafna Pharmaceuticals IPO | Sejal Architectural Glass IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 71.07 | 54.88 | ||||
| Promoter Shareholding (Post-Issue) | 42.6 | 36.85 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹63.92 Cr. | ₹322.00 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 10.65 | 20.38 |
In the Bafna Pharmaceuticals IPO Retail Individual Investors (RII) are offered 32,00,000 shares while in Sejal Architectural Glass IPO retail investors are offered 32,00,000 shares. Qualified Institutional Buyers (QIB) are offered in Bafna Pharmaceuticals IPO and 45,97,078 shares in Sejal Architectural Glass IPO.
| Bafna Pharmaceuticals IPO | Sejal Architectural Glass IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | ||
| QIB | 45,97,078 shares | |
| NII | 32,00,000 shares | 13,79,123 shares |
| RII | 32,00,000 shares | 32,17,954 shares |
| Employee | ||
| Others | ||
| Total | 64,00,000 shares | 91,94,155 shares |
Bafna Pharmaceuticals IPO subscribed 4.88x in total, whereas Sejal Architectural Glass IPO subscribed 9.90x.
| Bafna Pharmaceuticals IPO | Sejal Architectural Glass IPO | |
|---|---|---|
| QIB (times) | 4.26x | |
| NII (times) | 1.57x | 33.17x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 8.20x | 7.98x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 4.88x | 9.90x |
